Search
NEWS

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

By A Mystery Man Writer

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

CONSORT diagram. a Patients who had surgery; b Patients with

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

Frontiers Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

Landmark trials in breast cancer.pptx

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials - ScienceDirect

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

National Surgical Adjuvant Breast and Bowel Project (NSABP)

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. - Abstract - Europe PMC

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials - ScienceDirect

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC=Breast

CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial, Breast Cancer Research